Perflutren Protein Type A and Pneumococcal Conjugate Vaccine (13-Valent)
Determining the interaction of Perflutren Protein Type A and Pneumococcal Conjugate Vaccine (13-Valent) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: perflutren
Brand name: Definity, Optison
Synonyms: Perflutren, Perflutren Lipid Microspheres
Generic Name: pneumococcal 13-valent vaccine
Brand name: Prevnar 13
Synonyms: Pneumococcal 13-valent conjugate vaccine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Perflutren Protein Type A-Pneumococcal Conjugate Vaccine (7-Valent)
- Perflutren Protein Type A-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Perflutren Protein Type A-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Perflutren Protein Type A-Pneumovax 23
- Perflutren Protein Type A-PNV - Omega
- Perflutren Protein Type A-PNV Iron Polysaccharides, Folic Acid, DHA
- Pneumococcal Conjugate Vaccine (13-Valent)-Perflutren protein type a microsphere Intravenous
- Pneumococcal Conjugate Vaccine (13-Valent)-Perforomist
- Pneumococcal Conjugate Vaccine (13-Valent)-Perforomist, Symbicort
- Pneumococcal Conjugate Vaccine (13-Valent)-Pergolide
- Pneumococcal Conjugate Vaccine (13-Valent)-Pergonal
- Pneumococcal Conjugate Vaccine (13-Valent)-Peri-Colace